Table 1. The association of PBLD mRNA expression with the clinicopathological characteristics in 108 patients with HCC.

Variables	n	PBLD		P
		Low (n = 54)	High (n = 54)
Age (years)
<50	62	34	28	0.243
≥50	46	20	26
Gender
Male	97	50	47	0.340
Female	11	4	7
HBsAg
positive	99	48	51	0.296
negative	9	6	3
HBeAg
positive	14	7	7	1.000
negative	94	47	47
AFP* (ng/mL)
>400	60	34	26	0.121
≤400	48	20	28
Liver Cirrhosis
Absent	30	19	11	0.086
Present	78	35	43
Vascular invasion
Absent	83	40	44	0.494
Present	25	14	10
Intrahepatic metastasis
Absent	83	38	45	0.110
Present	25	16	9
Tumor size
≤5 cm	25	11	14	0.494
>5 cm	83	43	40
Tumor number
Single	81	37	44	0.120
Multiple	27	17	10
Tumor differentiation
Well	40	14	26	0.017
Moderate-Poor	68	40	28
AJCC stage
I/II	74	32	42	0.038
III/IV	34	22	12